Skip to main content
SpringerLink
Log in

Decision Resources has forecast that the hepatitis B drug market in China will more than double by 2012,

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Decision Resources Inc.China's Hepatitis B Virus Drug Market Will Grow to $800 Million by 2012. Media Release: 28 Aug 2008. Available from: URL: http://www.decisionresources.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Decision Resources has forecast that the hepatitis B drug market in China will more than double by 2012,. Pharmacoecon. Outcomes News 561, 10 (2008). https://doi.org/10.2165/00151234-200805610-00028

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805610-00028

Keywords

Search

Navigation